Growth often gets discussed in numbers, associating with valuation, revenue, expansion and the like. However, these figures can rarely explain how ...

I-Mab Biopharma has signed an agreement to divest its assets and business operations in China, becoming a US-based biotech company. The divesting will provide I-Mab with a healthy balance sheet, over ...

Upcoming anticipated milestones for givastomig (CLDN18.2 x 4-1BB bispecific), prioritized to be I-Mab’s lead program in January 2025: 1H 2026: Presentation of data from givastomig dose expansion ...

The long journey from cell culture to a purified monoclonal antibody (mAb) involves many sample processing steps, with clarification and filtration playing significant roles. However, clogs, complex ...

One of the most prominent names in the world of business is Pinagare Mogodi, the powerhouse behind MAB Group (Matsapa-A-Botshelo). There is a reason he has emerged as one of South Africa’s most ...

Malaysia Airlines’ MRO arm, MAB Engineering, is testing new technologies in the hangar and adapting its training strategies to improve maintenance efficiencies. The MRO recently debuted what it calls ...

New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for ...